Ethers of 3,4-dihydro-1-benzoxepin-5-one oxime to treat intestinal disorders
US4179516A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Feb 14, 1978 |
| Grant date | Dec 18, 1979 |
| Priority date | — |
| Expiry date | Feb 14, 1998 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D313/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Therapeutic compositions, particularly for treating intestinal disorders, and a method of treating colopathics by administering an effective amount of the compositions are described. The compositions contain a therapeutically effective amount of at least one isomer of the oximino group of the compound having the formula: ##STR1## in which: R is selected from the group consisting of halogen atoms and lower alkoxy groups; PA1 n is an integer 2 or 3, and PA1 Z.sub.1 and Z.sub.2 are the same or different lower alkyl groups, or PA1 NZ.sub.1 Z.sub.2 represents a saturated heterocyclic group which may have a second heteroatom selected from the group consisting of N and O, PA1 and the addition salts of the amino group with pharmaceutically acceptable acids, PA1 with a physiological acceptable excipient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.